Y Intercept (Hong Kong) LTD Genmab A/S Transaction History
Y Intercept (Hong Kong) LTD
- $1.58 Billion
- Q3 2024
A detailed history of Y Intercept (Hong Kong) LTD transactions in Genmab A/S stock. As of the latest transaction made, Y Intercept (Hong Kong) LTD holds 15,648 shares of GMAB stock, worth $307,796. This represents 0.02% of its overall portfolio holdings.
Number of Shares
15,648
Previous 15,512
0.88%
Holding current value
$307,796
Previous $389,000
2.06%
% of portfolio
0.02%
Previous 0.02%
Shares
10 transactions
Others Institutions Holding GMAB
# of Institutions
229Shares Held
52.1MCall Options Held
10.2KPut Options Held
25.5K-
Alliancebernstein L.P. New York, NY15.1MShares$298 Million0.13% of portfolio
-
Black Rock Inc. New York, NY5.08MShares$99.9 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA4.42MShares$87 Million0.02% of portfolio
-
Harding Loevner LP Bridgewater, NJ3.07MShares$60.3 Million0.44% of portfolio
-
Wellington Management Group LLP Boston, MA2.31MShares$45.4 Million0.01% of portfolio
About GENMAB A/S
- Ticker GMAB
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 658,292,992
- Market Cap $12.9B
- Description
- Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...